Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus


Karatoprak C. , Kilicarslan R., Cakirca M. , Aydin S. , OZKAN T., KOCAMAN O., ...Daha Fazla

BEZMIALEM SCIENCE, cilt.6, ss.1-5, 2018 (ESCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 6 Konu: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.14235/bs.2018.1050
  • Dergi Adı: BEZMIALEM SCIENCE
  • Sayfa Sayıları: ss.1-5

Özet

Objective: This study investigated how vildagliptin (a di-peptidyl peptidase 4 inhibitor) affects portal vein pressure and hepatosteatosis in patients with type 2 diabetes mellitus.